Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis 9.9. Comparison 9 Artemether-lumefantrine vs Artesunate plus amodiaquine, Outcome 9<br />
Sensitivity analysis: Total Failure Day 28 PCR unadjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 9 Artemether-lumefantrine vs Artesunate plus amodiaquine<br />
Outcome: 9 Sensitivity analysis: Total Failure Day 28 PCR unadjusted<br />
Study or subgroup AL6 AS+AQ Risk Ratio Weight Risk Ratio<br />
1 Total Failure (P. falciparum) Day 28 PCR unadjusted<br />
n/N n/N M-H,Random,95% CI M-H,Random,95% CI<br />
Faye 2003 SEN 0/147 9/349 1.2 % 0.12 [ 0.01, 2.12 ]<br />
Mutabingwa 2004 TZA 103/485 193/472 23.5 % 0.52 [ 0.42, 0.64 ]<br />
Guthmann 2004 AGO 2/61 4/64 3.3 % 0.52 [ 0.10, 2.76 ]<br />
Bukirwa 2005 UGA 102/202 133/201 24.2 % 0.76 [ 0.64, 0.90 ]<br />
Falade 2005 NGA 3/62 5/61 4.5 % 0.59 [ 0.15, 2.36 ]<br />
Owusu-Agyei 2006 GHA 42/152 22/151 16.9 % 1.90 [ 1.19, 3.02 ]<br />
Dorsey 2006 UGA 5/100 7/105 6.4 % 0.75 [ 0.25, 2.29 ]<br />
Adjei 2006 GHA 6/103 5/107 6.0 % 1.25 [ 0.39, 3.96 ]<br />
Kobbe 2007 GHA 23/103 15/96 14.0 % 1.43 [ 0.79, 2.57 ]<br />
Subtotal (95% CI) 1415 1606 100.0 % 0.88 [ 0.60, 1.27 ]<br />
Total events: 286 (AL6), 393 (AS+AQ)<br />
Heterogeneity: Tau 2 = 0.16; Chi 2 = 34.92, df = 8 (P = 0.00003); I 2 =77%<br />
Test <strong>for</strong> overall effect: Z = 0.70 (P = 0.49)<br />
2 Total Failure Day 28 PCR unadjusted (trials with baseline differences included)<br />
Faye 2003 SEN 0/147 9/349 0.9 % 0.12 [ 0.01, 2.12 ]<br />
Martensson 2003 TZA 14/197 57/206 10.6 % 0.26 [ 0.15, 0.45 ]<br />
Koram 2003 GHA 8/47 13/51 7.4 % 0.67 [ 0.30, 1.47 ]<br />
Van den Broek 2004 ZAR 13/100 31/97 10.1 % 0.41 [ 0.23, 0.73 ]<br />
Mutabingwa 2004 TZA 103/485 193/472 16.9 % 0.52 [ 0.42, 0.64 ]<br />
Guthmann 2004 AGO 2/61 4/64 2.4 % 0.52 [ 0.10, 2.76 ]<br />
Falade 2005 NGA 3/62 5/61 3.2 % 0.59 [ 0.15, 2.36 ]<br />
Bukirwa 2005 UGA 102/202 133/201 17.4 % 0.76 [ 0.64, 0.90 ]<br />
Owusu-Agyei 2006 GHA 42/152 22/151 12.1 % 1.90 [ 1.19, 3.02 ]<br />
Adjei 2006 GHA 6/103 5/107 4.3 % 1.25 [ 0.39, 3.96 ]<br />
Dorsey 2006 UGA 5/100 7/105 4.6 % 0.75 [ 0.25, 2.29 ]<br />
Kobbe 2007 GHA 23/103 15/96 10.0 % 1.43 [ 0.79, 2.57 ]<br />
0.002 0.1 1 10 500<br />
Favours AL6 Favours AS+AQ<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
(Continued ...)<br />
172